COMMENTARY: Movement is growing to expose hidden litigation funders

An insidious fiscal statement is happening wrong American courtrooms that astir radical ne'er perceive about. Third-party investors and immoderate overseas investors are pouring billions of dollars into lawsuits they did not originate, successful pursuit of 1 thing: outsized returns connected a litigation investment.

This is third-party litigation funding, known arsenic TPLF, and the increasing question to bring it into the unfastened is 1 of the astir important ineligible betterment efforts successful decades.

The Washington Health Innovation Council has been tracking this issue, and its 2024-25 yearly study documented an unmistakable signifier for its subordinate companies. Health-care innovators, from aesculapian instrumentality manufacturers to biopharmaceutical developers, are being targeted by litigation investors.

Here is however the instrumentality works. A litigation funder identifies a high-value firm defendant. Plaintiffs are recruited, often without being told who is underwriting the effort. Legal strategy is shaped astir maximizing a payout alternatively than astir the merits of the case. Settlements are influenced by declaration presumption that springiness extracurricular funders control. The plaintiff’s existent interests — the harm they allegedly suffered and the remedy — go secondary. As a result, the defendant, the tribunal and the nationalist are kept successful the dark.

What often goes unreported is however patients are brought into these cases successful the archetypal place. Plaintiff recruitment includes targeted advertizing campaigns designed to alarm mean Americans astir products they whitethorn person utilized safely for years, and these ads often invoke the FDA sanction and logo successful ways that connote authorities enactment oregon warning. A diligent who sees those ads and believes national regulators hold is not making an informed prime to articulation a lawsuit.

The toll connected American innovators is steep. Getting a caller aesculapian instrumentality oregon therapy to patients successful this state already takes years of objective improvement and regulatory review. When a institution indispensable simultaneously combat an battle backed by hedge money capital, resources are diverted, timelines lengthen and successful immoderate cases products ne'er scope Americans.

Pat Fogarty, the lawman wide counsel astatine AdvaMed, described this dynamic precisely successful a caller DC Journal piece, penning that litigation investors presumption the American tribunal strategy arsenic a marketplace for high-return investments alternatively than a mechanics for delivering justice.

The bully quality is that this is nary longer a fringe concern. In 2025, six states took decisive legislative action. Georgia led the tract with the astir broad package, the Courts Access and Consumer Protection Act, which requires extracurricular financiers to registry with authorities regulators, bars them from influencing litigation strategy and prohibits overseas backing of these arrangements. Arizona, Colorado, Kansas, Montana and Oklahoma enacted their versions of reform. Ohio and North Carolina person added their names to the list, a improvement the U.S. Chamber Institute for Legal Reform has highlighted arsenic further grounds of nationwide momentum.

The national representation is moving arsenic well. In February, Sen. Chuck Grassley, R-Iowa, and a radical of co-sponsors introduced the Litigation Funding Transparency Act of 2026, which would necessitate disclosure of third-party litigation financing successful national people actions and multi-district litigation proceedings. The Institute for Legal Reform and Lawyers for Civil Justice submitted a associated filing calling for amendment of the Federal Rules of Civil Procedure to found a azygous nationalist disclosure standard.

Ohio offers lessons for states opening this work. State Rep. Meredith Craig, a Republican and co-sponsor of related legislation, said the conjugation mattered most. “We yet had each large concern radical supporting the legislation, from the Ohio Farm Bureau to the Ohio State Medical Association. That wide conjugation showed this wasn’t astir helping 1 peculiar industry; it was astir protecting Ohioans and the integrity of our courts.”

On bipartisanship, she said, “Members connected some sides of the aisle agreed that it was clip to support our constituents and our businesses from being taken vantage of. We were capable to enactment authorities aside.”

For the innovation community, the stakes are high. When endless litigation backed by anonymous investors drains resources that would different spell into probe and objective development, patients hold longer for the treatments. And erstwhile overseas investors are involved, it raises nationalist information concerns astir who is gaining entree to delicate intelligence spot done discovery.

The Washington Health Innovation Council volition proceed to advocator for common-sense transparency betterment that ensures each enactment successful a courtroom — defendant, judge, plaintiff, the nationalist — has afloat accusation astir who is financing the litigation earlier them. State legislatures person shown that betterment is achievable. Congress present needs to travel their lead, and the Litigation Funding Transparency Act is simply a targeted starting point.

Innovators enactment hard to present high-quality products to patients. Justice should not beryllium a fiscal product, and bringing third-party litigation backing into the sunlight is the archetypal measurement toward making definite it is not.

Jack Kalavritinos is the laminitis of JK Strategies and a erstwhile authoritative successful the Bush and Trump administrations. He wrote this for InsideSources.com.